Annual Interest Expense
$9.00 M
+$1.10 M+13.92%
31 December 2023
Summary:
West Pharmaceutical Services annual interest expense is currently $9.00 million, with the most recent change of +$1.10 million (+13.92%) on 31 December 2023. During the last 3 years, it has risen by +$800.00 thousand (+9.76%). WST annual interest expense is now -50.55% below its all-time high of $18.20 million, reached on 31 December 2011.WST Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$700.00 K
-$800.00 K-53.33%
30 September 2024
Summary:
West Pharmaceutical Services quarterly interest expense is currently $700.00 thousand, with the most recent change of -$800.00 thousand (-53.33%) on 30 September 2024. Over the past year, it has dropped by -$2.20 million (-75.86%). WST quarterly interest expense is now -85.11% below its all-time high of $4.70 million, reached on 31 December 2010.WST Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$5.00 M
-$2.20 M-30.56%
30 September 2024
Summary:
West Pharmaceutical Services TTM interest expense is currently $5.00 million, with the most recent change of -$2.20 million (-30.56%) on 30 September 2024. Over the past year, it has dropped by -$4.50 million (-47.37%). WST TTM interest expense is now -72.97% below its all-time high of $18.50 million, reached on 30 September 2011.WST TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WST Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.9% | -75.9% | -47.4% |
| 3 y3 years | +9.8% | -61.1% | -35.1% |
| 5 y5 years | +7.1% | -66.7% | -42.5% |
WST Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +13.9% | -75.9% | at low | -47.4% | at low |
| 5 y | 5 years | at high | +13.9% | -75.9% | at low | -47.4% | at low |
| alltime | all time | -50.5% | +15.4% | -85.1% | at low | -73.0% | +21.9% |
West Pharmaceutical Services Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $700.00 K(-53.3%) | $5.00 M(-30.6%) |
| June 2024 | - | $1.50 M(-6.3%) | $7.20 M(-14.3%) |
| Mar 2024 | - | $1.60 M(+33.3%) | $8.40 M(-6.7%) |
| Dec 2023 | $9.00 M(+13.9%) | $1.20 M(-58.6%) | $9.00 M(-5.3%) |
| Sept 2023 | - | $2.90 M(+7.4%) | $9.50 M(+8.0%) |
| June 2023 | - | $2.70 M(+22.7%) | $8.80 M(+11.4%) |
| Mar 2023 | - | $2.20 M(+29.4%) | $7.90 M(0.0%) |
| Dec 2022 | $7.90 M(-3.7%) | $1.70 M(-22.7%) | $7.90 M(-10.2%) |
| Sept 2022 | - | $2.20 M(+22.2%) | $8.80 M(+4.8%) |
| June 2022 | - | $1.80 M(-18.2%) | $8.40 M(-1.2%) |
| Mar 2022 | - | $2.20 M(-15.4%) | $8.50 M(+3.7%) |
| Dec 2021 | $8.20 M(0.0%) | $2.60 M(+44.4%) | $8.20 M(+6.5%) |
| Sept 2021 | - | $1.80 M(-5.3%) | $7.70 M(-3.8%) |
| June 2021 | - | $1.90 M(0.0%) | $8.00 M(-1.2%) |
| Mar 2021 | - | $1.90 M(-9.5%) | $8.10 M(-1.2%) |
| Dec 2020 | $8.20 M(-3.5%) | $2.10 M(0.0%) | $8.20 M(0.0%) |
| Sept 2020 | - | $2.10 M(+5.0%) | $8.20 M(0.0%) |
| June 2020 | - | $2.00 M(0.0%) | $8.20 M(0.0%) |
| Mar 2020 | - | $2.00 M(-4.8%) | $8.20 M(-3.5%) |
| Dec 2019 | $8.50 M(+1.2%) | $2.10 M(0.0%) | $8.50 M(-2.3%) |
| Sept 2019 | - | $2.10 M(+5.0%) | $8.70 M(+1.2%) |
| June 2019 | - | $2.00 M(-13.0%) | $8.60 M(-2.3%) |
| Mar 2019 | - | $2.30 M(0.0%) | $8.80 M(+4.8%) |
| Dec 2018 | $8.40 M(+7.7%) | $2.30 M(+15.0%) | $8.40 M(+2.4%) |
| Sept 2018 | - | $2.00 M(-9.1%) | $8.20 M(+7.9%) |
| June 2018 | - | $2.20 M(+15.8%) | $7.60 M(0.0%) |
| Mar 2018 | - | $1.90 M(-9.5%) | $7.60 M(-2.6%) |
| Dec 2017 | $7.80 M(-3.7%) | $2.10 M(+50.0%) | $7.80 M(+9.9%) |
| Sept 2017 | - | $1.40 M(-36.4%) | $7.10 M(-10.1%) |
| June 2017 | - | $2.20 M(+4.8%) | $7.90 M(+2.6%) |
| Mar 2017 | - | $2.10 M(+50.0%) | $7.70 M(-4.9%) |
| Dec 2016 | $8.10 M | $1.40 M(-36.4%) | $8.10 M(-15.6%) |
| Sept 2016 | - | $2.20 M(+10.0%) | $9.60 M(-13.5%) |
| June 2016 | - | $2.00 M(-20.0%) | $11.10 M(-11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $2.50 M(-13.8%) | $12.50 M(-11.3%) |
| Dec 2015 | $14.10 M(-14.5%) | $2.90 M(-21.6%) | $14.10 M(-6.0%) |
| Sept 2015 | - | $3.70 M(+8.8%) | $15.00 M(-5.1%) |
| June 2015 | - | $3.40 M(-17.1%) | $15.80 M(-4.8%) |
| Mar 2015 | - | $4.10 M(+7.9%) | $16.60 M(+0.6%) |
| Dec 2014 | $16.50 M(-2.9%) | $3.80 M(-15.6%) | $16.50 M(-0.6%) |
| Sept 2014 | - | $4.50 M(+7.1%) | $16.60 M(+0.6%) |
| June 2014 | - | $4.20 M(+5.0%) | $16.50 M(+0.6%) |
| Mar 2014 | - | $4.00 M(+2.6%) | $16.40 M(-3.5%) |
| Dec 2013 | $17.00 M(+1.8%) | $3.90 M(-11.4%) | $17.00 M(+2.4%) |
| Sept 2013 | - | $4.40 M(+7.3%) | $16.60 M(0.0%) |
| June 2013 | - | $4.10 M(-10.9%) | $16.60 M(-2.9%) |
| Mar 2013 | - | $4.60 M(+31.4%) | $17.10 M(+1.8%) |
| Dec 2012 | $16.70 M(-8.2%) | $3.50 M(-20.5%) | $16.80 M(-5.1%) |
| Sept 2012 | - | $4.40 M(-4.3%) | $17.70 M(-0.6%) |
| June 2012 | - | $4.60 M(+7.0%) | $17.80 M(0.0%) |
| Mar 2012 | - | $4.30 M(-2.3%) | $17.80 M(-2.2%) |
| Dec 2011 | $18.20 M(+8.3%) | $4.40 M(-2.2%) | $18.20 M(-1.6%) |
| Sept 2011 | - | $4.50 M(-2.2%) | $18.50 M(+1.6%) |
| June 2011 | - | $4.60 M(-2.1%) | $18.20 M(+4.0%) |
| Mar 2011 | - | $4.70 M(0.0%) | $17.50 M(+4.2%) |
| Dec 2010 | $16.80 M(+10.5%) | $4.70 M(+11.9%) | $16.80 M(+3.7%) |
| Sept 2010 | - | $4.20 M(+7.7%) | $16.20 M(+2.5%) |
| June 2010 | - | $3.90 M(-2.5%) | $15.80 M(+2.6%) |
| Mar 2010 | - | $4.00 M(-2.4%) | $15.40 M(+0.7%) |
| Dec 2009 | $15.20 M(-5.0%) | $4.10 M(+7.9%) | $15.30 M(+4.8%) |
| Sept 2009 | - | $3.80 M(+8.6%) | $14.60 M(-3.3%) |
| June 2009 | - | $3.50 M(-10.3%) | $15.10 M(-4.4%) |
| Mar 2009 | - | $3.90 M(+14.7%) | $15.80 M(-1.3%) |
| Dec 2008 | $16.00 M(+10.3%) | $3.40 M(-20.9%) | $16.00 M(+27.0%) |
| Sept 2008 | - | $4.30 M(+2.4%) | $12.60 M(+51.8%) |
| June 2008 | - | $4.20 M(+2.4%) | $8.30 M(+102.4%) |
| Mar 2008 | - | $4.10 M | $4.10 M |
| Dec 2007 | $14.50 M | - | - |
FAQ
- What is West Pharmaceutical Services annual interest expense?
- What is the all time high annual interest expense for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual interest expense year-on-year change?
- What is West Pharmaceutical Services quarterly interest expense?
- What is the all time high quarterly interest expense for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly interest expense year-on-year change?
- What is West Pharmaceutical Services TTM interest expense?
- What is the all time high TTM interest expense for West Pharmaceutical Services?
- What is West Pharmaceutical Services TTM interest expense year-on-year change?
What is West Pharmaceutical Services annual interest expense?
The current annual interest expense of WST is $9.00 M
What is the all time high annual interest expense for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual interest expense is $18.20 M
What is West Pharmaceutical Services annual interest expense year-on-year change?
Over the past year, WST annual interest expense has changed by +$1.10 M (+13.92%)
What is West Pharmaceutical Services quarterly interest expense?
The current quarterly interest expense of WST is $700.00 K
What is the all time high quarterly interest expense for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly interest expense is $4.70 M
What is West Pharmaceutical Services quarterly interest expense year-on-year change?
Over the past year, WST quarterly interest expense has changed by -$2.20 M (-75.86%)
What is West Pharmaceutical Services TTM interest expense?
The current TTM interest expense of WST is $5.00 M
What is the all time high TTM interest expense for West Pharmaceutical Services?
West Pharmaceutical Services all-time high TTM interest expense is $18.50 M
What is West Pharmaceutical Services TTM interest expense year-on-year change?
Over the past year, WST TTM interest expense has changed by -$4.50 M (-47.37%)